Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EE/DNG versus EE/DRSP for insulin resistance in women with PCOS
TCTR20260914005Phase 3Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol, dienogest, drospirenone in polycystic ovary syndrome (PCOS), sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
ethinyl estradioldienogestdrospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on TCTR20260914005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260914005.